In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone from niche diabetes treatments to household names, reshaping how America thinks about weight loss
Who Can Receive Weight Loss Medications Branded weight loss medications are ideal for adults with a BMI of 30 or more, or 27 and above with a weight-associated condition
A new study in the BMJ showed GLP-1 drugs may prevent multiple substance use disorders and reduce harms
Improving metabolism, aiding fat breakdown, and enhancing muscle tone
Clinical Profile of Exenatide To understand subsequent innovations, its helpful to summarize exenatides clinical profile (as the first GLP-1 RA): Efficacy: In trials, twice-daily exenatide (10 g BID) typically reduced HbAc by approximately 0.8%1.0% more than placebo by 30 weeks ( [61] ) ( [101] )